Connect with us

Business

Filament Health posts $5M loss in 2024, faces liquidity concerns

Published

on



Filament Health Corp. (OTCQB: FLHLF) (Cboe CA: FH) reported a net loss of $4.97 million for 2024 while the botanical psychedelic drug developer expanded its clinical trial programs and intellectual property portfolio.

The Vancouver-based company announced in its year-end financial results that cash reserves stood at just $391,237 as of Dec. 31, 2024, down from $1.83 million at the end of 2023.

“Over the course of 2024, we continued to expand Filament’s position as a leading global supplier of cGMP botanical psilocybin,” Benjamin Lightburn, co-founder and CEO, said in a statement. “While this past year presented challenges, we remain steadfast in our mission to unlock the therapeutic potential of botanical psilocybin and our other botanical drug candidates.”

Lightburn pointed to the company’s focus on advancing its lead program, PEX010, through clinical trials globally. The emphasis on treating substance use disorders saw validation from positive trial results showing efficacy in severe alcohol use disorder patients, according to the company.

Last month, the company reported that a single dose of PEX010 reduced heavy drinking days by more than 50% over a 12-week observation period in an open-label Phase 2 clinical trial at Psychiatric Centre Copenhagen.

Financial results showed annual revenue of $616,678, down significantly from $2.13 million in 2023. The company used $4.9 million in cash for operating activities during 2024.

Filament’s financial statements included a going concern note from auditors, indicating “material uncertainties regarding the Company’s ability to execute its business plan and continue in the normal course of operations” due to negative cash flow and an accumulated deficit of $36.12 million.

During 2024, Filament boosted its intellectual property position with the acceptance of 12 patents by IP Australia, five patents by the Canadian Intellectual Property Office, and three patents by the United States Patent and Trademark Office related to the development of botanical psychedelic drugs.

The company also expanded its international reach by completing exports of botanical psilocybin to multiple countries. Filament in January announced shipments to the University of Wisconsin-Madison for FDA-approved clinical trials and previously reported first-ever exports of botanical psilocybin to Israel and Australia.

Filament operates with a Health Canada Dealer’s License, allowing it to possess, produce and transport psilocybin and other compounds found in natural fungi. The company manufactures standardized botanical psychedelic drug candidates including oral psilocybin (PEX010) as well as oral and sublingual psilocin (PEX020 and PEX030).

The company developed a joint venture called Magdalena Biosciences with Jaguar Health to develop natural psychedelic medicines. In December, Magdalena successfully completed an import of six kilograms of coca leaf from Peru to Filament’s Metro Vancouver research facility.



Source link

mscannabiz.com
Author: mscannabiz.com

MScannaBIZ for all you Mississippi Cannabis News and Information.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Business

Proposed Ohio cannabis tax increase tabled by lawmakers

Published

on



A tax hike on marijuana products requested by Ohio Gov. Mike DeWine was not included in a state budget plan released this week, possibly saving state cannabis companies from having to raise prices at dispensaries.

Republican leaders at the state capitol insisted this week they would avoid raising taxes whenever possible, including on the newly established recreational cannabis trade, the Ohio Capital Journal reported.

“There are no tax increases in this budget,” Rep. Brian Stewart, the chairman of the House Finance Committee, told the Journal. “We are not raising taxes on sports betting, marijuana or tobacco products.”

Stewart was responding to a specific budget request from DeWine that called for raising cannabis tax rates from 10% to 20% to help pay for “local jail improvements, law enforcement, poison control, assistance in having old cannabis-related convictions expunged, and addiction services.”

Instead, Ohio lawmakers made clear this week they are not DeWine’s to command and released a far different fiscal agenda than the state’s chief executive requested, the Journal reported. DeWine still has line-item veto power, so changes may still be ahead.

Lawmakers have until July to approve a new budget plan.

DeWine’s request appears to be part of a small but significant national trend of states relying increasingly on marijuana taxes to fund state coffers, NORML noted in a blog post on Thursday. California, Maryland, Michigan and New Jersey also have either pending recreational cannabis tax hikes or legislative proposals to do so, the marijuana activist organization pointed out.



Source link

mscannabiz.com
Author: mscannabiz.com

MScannaBIZ for all you Mississippi Cannabis News and Information.

Continue Reading

Business

City View Green decides to officially ditch cannabis for tech

Published

on



City View Green Holdings (CSE: CVGR) (OTC Pink: CVGRF) recently warned investors it was considering a pivot out of cannabis and becoming an investment issuer. Now it’s making that official.

The company has proposed to spin out its wholly owned subsidiary, 2590672 Ontario Inc. Following the spin-out transaction, the company said it would remain a reporting issuer to complete a reverse take-over transaction with a business that has yet to be identified.

City View also said that the spin-out would allow shareholders to realize the expected growth and returns from the cannabis sector through direct ownership in the “SubCo” – or the spin-out property – and that it was expected to file with the Canadian Securities Exchange to list the shares there. That exchange ratio has yet to be determined.

Target acquisition

As part of the proposed plan, City View told the market that it has entered into an agreement of principle with an arm’s length party referred to as the “Target.” City View will buy an ownership interest in said Target in exchange for the issuance of shares in the capital of City View.

While it didn’t name the company, City View did say that the Target is a technology company with a primary focus on assisting online creators and influencers to monetize their YouTube, Twitch and X livestreams by matching the individual creators and influencers with brands.

“The creators and influencers will use the proprietary live broadcast software to integrate the ads into their livestreams. The Target, using AI, will be able to track all interactions by the viewers with the ads, bill the advertisers accordingly and remit payment to the creators and influencers,” the company said in its statement.

Despite the lengthy description, City View acknowledged it is still doing its due diligence on the company and has signed no definitive agreement.

The proposed plan is also dependent upon a shareholder vote approving the move.



Source link

mscannabiz.com
Author: mscannabiz.com

MScannaBIZ for all you Mississippi Cannabis News and Information.

Continue Reading

AFC Gamma

Standard Wellness received $14M facility from AFC, retires other debt

Published

on



Standard Wellness Holdings LLC secured a $14 million senior secured credit facility from Advanced Flower Capital (NASDAQ: AFCG), the companies announced Thursday.

The vertically integrated cannabis company will use the funding to refinance existing debt, including full repayment of its debt facility with Focus Growth Capital Partners and early repayment of a seller note with Columbia Care, according to the announcement. That debt was incurred when Standard Wellness acquired the Cannabist dispensary in Springville, Utah.

Additionally, the funds will fully finance the acquisition of a dispensary license in St. Louis, though that acquisition remains subject to regulatory approval.

The new credit facility bears an interest rate of 12.5% with AFC, a longstanding lender to the cannabis industry, specifically privately owned companies.

Kyle Ciccarello, CFO of Standard Wellness, said the repayment of the Focus Growth debt and early retirement of the Columbia Care note “reflect Standard Wellness’s proactive approach to managing its financial obligations and optimizing its capital structure.”

The AFC credit facility will help Standard streamline its debt structure, eliminate legacy obligation and invest in strategic acquisitions, according to Maloof.

The St. Louis dispensary acquisition is described as a key component of the company’s long-term growth strategy.

Founded in 2017 in Ohio, Standard Wellness operates across Ohio, Missouri and Utah, and has cultivation, processing and dispensary licenses in Maryland. The company operates five retail locations under The Forest brand and employs approximately 350 people.

Standard made the first-ever legal marijuana sale in Ohio through its dispensary The Forest Sandusky and completing the first delivery to a Utah pharmacy in February 2020, according to the company.

Gramercy Capital Group LLC (through INTE Securities LLC) served as financial advisor, while Feuerstein Kulick LLP acted as legal counsel to Standard Wellness.



Source link

mscannabiz.com
Author: mscannabiz.com

MScannaBIZ for all you Mississippi Cannabis News and Information.

Continue Reading
Industry6 hours ago

Former New York Knick Iman Shumpert debuts ‘TSA Approved’ legal cannabis brand

Business6 hours ago

Proposed Ohio cannabis tax increase tabled by lawmakers

Mississippi Cannabis News7 hours ago

Mississippi Medical Cannabis Program: A Complete Guide for Patients and Businesses – Respect My Region

Business9 hours ago

City View Green decides to officially ditch cannabis for tech

Industry10 hours ago

How New York pot pioneers made it to legal dispensary shelves

AFC Gamma10 hours ago

Standard Wellness received $14M facility from AFC, retires other debt

adult-use cannabis11 hours ago

Vladimir Bautista is leading Happy Munkey’s legacy-to-legal takeover

Alabama12 hours ago

Southern lawmakers float tighter controls on consumable hemp

Business13 hours ago

Innovative Industrial faces few good options with bankrupt tenants

Business1 day ago

Innocan Pharma 2024 earnings benefit from its beauty products

Business1 day ago

Colorado gets its first psychedelic treatment center

Business1 day ago

Delota continues on path to profitability with positive fourth-quarter results

Business2 days ago

Rubicon Organics revenue rises in 2024 with successful vape launch

Business2 days ago

Cannabis signals from Trump growing increasingly murky

Business2 days ago

FBI tells Delaware must revise background check request, putting rec market launch on hold

Business2 days ago

Filament Health posts $5M loss in 2024, faces liquidity concerns

Business2 days ago

Illinois sales fall again in February

Business2 days ago

New Hampshire Senate committee kills marijuana bills, including rec legalization

Mississippi Cannabis News2 days ago

What to know about getting a medical marijuana card in Mississippi – supertalk.fm

Banking2 days ago

Safe Harbor Financial lending income soars in 2024, but company still lands in the red

Mississippi Cannabis News2 days ago

Hemp THC ban bill facing challenges in MS Senate. Read why – Yahoo

Business2 days ago

Grown Rogue’s 2024 sales climb 16%, but losses widen

Mississippi Cannabis News2 days ago

Mississippi Says Medical Marijuana Is Legal—Just Don't Talk About It – Reason Magazine

Mississippi Cannabis News2 days ago

Senate considers House bill regulating hemp products – Mississippi Public Broadcasting

Trending